USS Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.7M Buy
104,700
+10,560
+11% +$694K 0.02% 371
2026
Q1
$6.7M Buy
94,140
+2,976
+3% +$235K 0.03% 315
2025
Q4
$7.48M Buy
91,164
+7,199
+9% +$561K 0.03% 273
2025
Q3
$6.3M Hold
83,965
– – 0.03% 305
2025
Q2
$6.22M Buy
83,965
+2,675
+3% +$186K 0.04% 303
2025
Q1
$6.56M Sell
81,290
-14,700
-15% -$1.26M 0.05% 270
2024
Q4
$7.5M Sell
95,990
-21,415
-18% -$1.82M 0.05% 277
2024
Q3
$11M Buy
117,405
+14,161
+14% +$1.19M 0.08% 212
2024
Q2
$8.05M Buy
103,244
+1,562
+2% +$127K 0.06% 256
2024
Q1
$9.24M Buy
101,682
+86,982
+592% +$7.24M 0.08% 219
2023
Q4
$1.14M Buy
14,700
+10,096
+219% +$707K 0.01% 536
2023
Q3
$313K Hold
4,604
– – ﹤0.01% 577
2023
Q2
$374K Hold
4,604
– – ﹤0.01% 590
2023
Q1
$378K Buy
+4,604
New +$329K 0.01% 575

Other funds holding GEHC

USS Investment Management's GEHC Position: Q2 2026 in Review

USS Investment Management increased its GE HealthCare (GEHC) stake by 11% in Q2 2026, buying an estimated $694K and bringing the position to 104,700 shares worth $6.7M. The position accounts for 0.02% of the portfolio, ranked #371.

USS Investment Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $11M in Q3 2024. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • USS Investment Management held 104,700 shares of GE HealthCare worth $6.7M as of Q2 2026.
  • USS Investment Management bought 10,560 GE HealthCare shares in Q2 2026, an estimated $694K.
  • GE HealthCare made up 0.02% of USS Investment Management's portfolio in Q2 2026, its #371 holding.
  • USS Investment Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • USS Investment Management's GE HealthCare position peaked at $11M in Q3 2024.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.